Mode
Text Size
Log in / Sign up

Epithelioid Sarcoma

Part of Cancer

Subtypes of Epithelioid Sarcoma

Osteosarcoma 5 Soft tissue sarcoma 4 Ewing's Sarcoma 2 Kaposi Sarcoma 1 Rhabdomyosarcoma 1 Leiomyosarcoma 0 Phyllodes tumor 0 Sarcoma 0

14 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Epithelioid Sarcoma

4 trials tracked for Epithelioid Sarcoma.

4Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4
  1. Phase 2 Trial of Dasatinib in Advanced Sarcomas Completed
  2. Phase 2 Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Completed
  3. Phase 2 A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma Completed
  4. Phase 2 Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

Review of a case report on epithelioid clear cell mesothelioma in a 76-year-old male with 24 months follow-up
Oncology Sys. Review
Review of a case report on epithelioid clear cell mesothelioma in a 76-year-old male with 24 months follow-up A 76-year-old man with rare cancer stayed cancer-free for two years
This publication is a review of a single case report involving a 76-year-old male with epithelioid clear cell mesothelioma. The patient had …
A 76-year-old man with a rare form of cancer had no signs of the disease returning after two years, offering hope for others facing this dif…
Review of gynecologic malignancies highlights dormant tumor cells as a therapeutic target
Oncology Sys. Review
Review of gynecologic malignancies highlights dormant tumor cells as a therapeutic target Doctors find dormant cancer cells could help stop gynecologic cancer from coming back after treatment
This narrative review examines ovarian, cervical, endometrial, and uterine sarcoma cancers. The authors synthesize evidence regarding dorman…
A review shows that sleeping cancer cells might cause tumors to return. Targeting these hidden cells could help prevent recurrence in ovaria…
Undifferentiated Pleomorphic Sarcoma Recurrence Observed two months Postoperatively in Case Report of Gastric Mass
Geriatrics & Aging Sys. Review
Undifferentiated Pleomorphic Sarcoma Recurrence Observed two months Postoperatively in Case Report of Gastric Mass Cancer returns quickly after surgery and chemo for a 71-year-old woman
This case report and literature review describes a 71-year-old female with undifferentiated pleomorphic sarcoma treated with R0 resection, s…
A 71-year-old woman with rare stomach tumors had surgery and chemo, but the cancer came back just two months later.